Efficacy and Safety of Endoscopic Stenting for Crohn's Disease Related Strictures: A Systematic Review and Meta-analysis
The Korean Journal of Gastroenterology · 25.10.2022 · 80 (4) · 177-185
DOI: 10.4166/kjg.2022.077 ↗Kurz gefasst
Metaanalyse in der Zeitschrift The Korean Journal of Gastroenterology, erschienen am 25.10.2022. Verfasst von Suprabhat Giri und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Nizam's Institute of Medical Sciences, Hyderabad, India. Hauptthemen laut MEDLINE: Crohn Disease. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Nizam's Institute of Medical Sciences, Hyderabad, India.
- Department of Gastroenterology, Seth GS Medical College and KEM Hospital, Mumbai, India.
- Department of Digestive Diseases and Clinical Nutrition, Tata Memorial Hospital, Mumbai, India.
ORCID-Profile: Aditya Kale
Zitieren
APA
Giri, S., Gopan, A., Sundaram, S., & Kale, A. (2022). Efficacy and Safety of Endoscopic Stenting for Crohn's Disease Related Strictures: A Systematic Review and Meta-analysis. The Korean Journal of Gastroenterology, 80(4), 177-185. https://doi.org/10.4166/kjg.2022.077
Vancouver
Giri S, Gopan A, Sundaram S, Kale A. Efficacy and Safety of Endoscopic Stenting for Crohn's Disease Related Strictures: A Systematic Review and Meta-analysis. The Korean Journal of Gastroenterology. 2022;80(4):177-185. doi:10.4166/kjg.2022.077
BibTeX
@article{Giri2022,
author = {Giri, Suprabhat and Gopan, Amrit and Sundaram, Sridhar and Kale, Aditya},
title = {Efficacy and Safety of Endoscopic Stenting for Crohn's Disease Related Strictures: A Systematic Review and Meta-analysis},
journal = {The Korean Journal of Gastroenterology},
year = {2022},
volume = {80},
number = {4},
pages = {177--185},
doi = {10.4166/kjg.2022.077}
}
EUVIMED